AAAAAA
Results:
1-8
|
Results: 8
Authors:
Isaksen, B
Fagerhol, MK
Citation: B. Isaksen et Mk. Fagerhol, Calprotectin inhibits matrix metalloproteinases by sequestration of zinc, J CL PATH-M, 54(5), 2001, pp. 289-292
Authors:
Welle, I
Bakke, PS
Eide, GE
Fagerhol, MK
Omenaas, E
Gulsvik, A
Citation: I. Welle et al., Increased circulating levels of alpha(1)-antitrypsin and calprotectin are associated with reduced gas diffusion in the lungs, EUR RESP J, 17(6), 2001, pp. 1105-1111
Authors:
Richter, KK
Wang, JR
Fagerhol, MK
Hauer-Jensen, M
Citation: Kk. Richter et al., Radiation-induced granulocyte transmigration predicts development of delayed structural changes in rat intestine, RADIOTH ONC, 59(1), 2001, pp. 81-85
Authors:
Fagerhol, MK
Citation: Mk. Fagerhol, Calprotectin, a faecal marker of organic gastrointestinal abnormality, LANCET, 356(9244), 2000, pp. 1783-1784
Authors:
Tibble, JA
Sigthorsson, G
Bridger, S
Fagerhol, MK
Bjarnason, I
Citation: Ja. Tibble et al., Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease, GASTROENTY, 119(1), 2000, pp. 15-22
Authors:
Kristinsson, J
Roseth, AG
Sundset, A
Nygaard, K
Loberg, EM
Paulsen, JE
Aadland, E
Fagerhol, MK
Citation: J. Kristinsson et al., Granulocyte marker protein is increased in stools from rats with azoxymethane-induced colon cancer, SC J GASTR, 34(12), 1999, pp. 1216-1223
Authors:
Roseth, AG
Schmidt, PN
Fagerhol, MK
Citation: Ag. Roseth et al., Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease, SC J GASTR, 34(1), 1999, pp. 50-54
Authors:
Tibble, JA
Sigthorsson, G
Foster, R
Scott, D
Fagerhol, MK
Roseth, A
Bjarnason, I
Citation: Ja. Tibble et al., High prevalence of NSAID enteropathy as shown by a simple faecal test, GUT, 45(3), 1999, pp. 362-366
Risultati:
1-8
|